CROI 2017: Hepatitis C Treatment Can Be Provided Successfully at Syringe Exchange Sites
- Details
- Category: People Who Inject Drugs
- Published on Thursday, 13 April 2017 00:00
- Written by Liz Highleyman
Administering direct-acting antiviral therapy for people who inject drugs at a syringe exchange site led to high sustained response rates in a pilot study in New York City, researchers reported at the recent Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle. Expanding treatment for this population could reduce hepatitis C virus (HCV) transmission and ultimately help eliminate hepatitis C as a public health threat.
CROI 2017: Accelerated Linkage to HIV Care Improves Retention by a Third
- Details
- Category: Global Access
- Published on Thursday, 13 April 2017 00:00
- Written by Carole Leach-Lemens
Close to 60% of adults benefitting from point-of-care CD4 cell count testing at HIV testing sites, accelerated antiretroviral therapy (ART) initiation, and SMS appointment reminders were retained in care after 1 year, compared to just 44% of those receiving the standard of care in Mozambique, according to findings from the Engage4Health study presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2017) in Seattle.
CROI 2017: Higher than Expected HCV Prevalence Among HIV- Gay Men in Amsterdam PrEP Program
- Details
- Category: HIV/HCV Coinfection
- Published on Wednesday, 22 March 2017 00:00
- Written by Liz Highleyman
An unexpectedly high number of HIV-negative gay and bisexual men taking pre-exposure prophylaxis (PrEP) in Amsterdam were found to have hepatitis C virus (HCV) infection, suggesting HCV is being transmitted sexually between men with and without HIV, according to a presentation last month at the Conference on Retroviruses and Opportunistic Infections in Seattle.
CROI 2017: Test and Treat Study Shows Second Phase Is Finding More People with HIV
- Details
- Category: Global Access
- Published on Thursday, 13 April 2017 00:00
- Written by Keith Alcorn
After a second wave of intensive household testing, a large study of the "test and treat" strategy in Zambia is diagnosing more people with HIV, getting more people onto treatment, and reducing the time between diagnosis and starting treatment, findings from the PopART study presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2017) show.
CROI 2017: 1 in 5 HIV+ Men in U.K. Who Say They Are Heterosexual Caught HIV from Another Man
- Details
- Category: HIV/AIDS Epidemiology & Mortality
- Published on Sunday, 19 March 2017 00:00
- Written by Gus Cairns
A genetic analysis of a large database of people with HIV in care in the U.K. shows that 18% of HIV-positive men who claim to be exclusively heterosexual in fact belong to clusters of linked infections that consist only of men. The data were presented by Manon Ragonnet-Cronin and colleagues from Edinburgh University at the recent Conference on Retroviruses and Opportunistic Infections in Seattle.
More Articles...
- CROI 2017: Simple Risk Score Can Identify Gay Men Who May Have Acute HIV Infection
- CROI 2017: Better Depression Care Could Improve Outcomes for HIV Treatment Programs
- CROI 2017: Peer Navigators Improve Linkage to HIV Care and Retention in South African Study
- CROI 2017: Finding Men with HIV -- and Keeping Them in Treatment
- CROI 2017: How Does Vedolizumab Antibody Therapy Lead to Sustained Viral Remission?
- CROI 2017: Bone Density Improves in People Who Switch from Tenofovir DF to Tenofovir Alafenamide
- CROI 2017: Long-Term Darunavir/Ritonavir Modestly Increases Risk of Cardiovascular Disease
- CROI 2017: Dolutegravir Monotherapy Fails to Maintain Viral Suppression
- CROI 2017: Integrase Inhibitors May Increase Risk of IRIS in Late Presenters for HIV Treatment
- CROI 2017: HIV's Milder Cousin May Be Less Mild than Previously Thought
- CROI 2017: Bacterial Vaginosis Does Not Affect Efficacy of Oral PrEP in Women
- CROI 2017: Studies Look at Brain and Cognitive Changes in People with HIV As They Age
- CROI 2017: Point-of-Care Testing Improves Infant HIV Diagnosis Rate, Treatment, and Retention
- CROI 2017: Will There Be a New Wave of HIV Among People Who Inject Drugs in the U.S.?
- CROI 2017: DAA Therapy Cures HIV/HCV Coinfected People with Decompensated Cirrhosis or Transplants
- CROI 2017: Prednisone Reduces Risk of Developing TB-IRIS after Starting Antiretroviral Treatment
- CROI 2017: Several New Candidates in HIV Drug Pipeline Discussed at Conference
- CROI 2017: Timothy Brown, the Berlin Patient, Celebrates a Decade Cured of HIV
- CROI 2017: Bone Marrow Transplant Patient Off ART for 288 Days Without HIV Rebound
- CROI 2017: Time with Transmissible HIV Viral Load Has Fallen By Three-Quarters Since 2000
- CROI 2017: Treatment-as-Prevention Study Sees Substantial Drug Resistance, but No Impact on HIV Therapy
- CROI 2017: How Should HIV Self-Testing Be Provided?
- CROI 2017: Isoniazid Preventive Therapy for TB Reduces Risk of Death for People Living with HIV
- CROI 2017: New HIV Capsid Inhibitors Show High Potency and Prolonged Activity in Early Studies
- CROI 2017: STI Rates Among PrEP Users Are High, But Evidence that PrEP Increases Them Is Inconclusive
- CROI 2017: Monoclonal Antibodies Show Promise for HIV+ People with Few Treatment Options
- CROI 2017: Science, Community, and Political Will Can End HIV Epidemic, Says New York Commissioner
- CROI 2017: Efavirenz/ Tenofovir/Emtricitabine Less Likely to Cause Adverse Birth Outcomes
- CROI 2017: Unique Case of PrEP Failure Without Drug Resistance Reported in Amsterdam
- CROI 2017: New NNRTI Doravirine Shows Good Efficacy in Phase 3 Study
- CROI 2017: Spanish HIV Vaccine Induces Control Off ART in Nearly 40% of Recipients
- CROI 2017: Stopping Smoking Cuts Risk of Some Cancers Quickly in People with HIV
- CROI 2017: Triple Tuberculosis Regimen Beats XDR-TB in First Trial
- CROI 2017: Glecaprevir/ Pibrentasvir for HCV Can Be Safely Administered with Common Antiretrovirals
- CROI 2017: Are HIV/HCV Coinfected People Cured with DAAs at Increased Risk for Liver Cancer?
- CROI 2017: Changes In Viral Suppression Over Time Reveal Disparities in HIV Care
- CROI 2017: STI Prophylaxis in PrEP Users Reduces Syphilis and Chlamydia, but Not Gonorrhea
- CROI 2017: Infants Treated Within Days of Birth Can Clear HIV Reservoir Rapidly
- CROI 2017: A Combination of Factors Has Reduced HIV Infections in Hard-Hit Part of Africa
- CROI 2017: Treatment or Watchful Waiting for Cervical Abnormalities in Women with HIV?
- CROI 2017: Integrase Inhibitor Bictegravir Matches Dolutegravir for First-Line HIV Treatment
- CROI 2017: Dual Antiretroviral Regimen Maintains Durable HIV Suppression after Switch
Web Design and Development by